Protagonist Therapeutics ... (PTGX)
undefined
undefined%
At close: undefined
41.08
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 60.00M 26.58M 27.36M 28.63M 231.00K 30.93M 20.06M - - -
Cost of Revenue - 1.03M 2.77M - - - - 317.00K 247.00K -
Gross Profit 60.00M 25.55M 24.58M 28.63M 231.00K 30.93M 20.06M -317.00K -247.00K -
Operating Income -93.65M -131.37M -125.84M -64.52M -80.52M -42.27M -37.90M -32.67M -14.79M -9.32M
Interest Income 14.90M 4.06M 443.00K 900.00K 2.81M 2.57M 948.00K 242.00K 19.00K 16.00K
Pretax Income -78.95M -127.39M -125.55M -64.84M -77.88M -39.72M -36.96M -37.18M -14.86M -11.07M
Net Income -78.95M -123.41M -122.63M -66.15M -77.19M -38.92M -36.96M -37.18M -14.86M -11.07M
Selling & General & Admin 33.49M 31.74M 27.20M 18.64M 15.75M 13.70M 11.78M 6.96M 2.96M 1.86M
Research & Development 120.16M 126.22M 126.01M 74.51M 65.00M 59.50M 46.18M 25.70M 11.83M 7.46M
Other Expenses - -80.00K -149.00K -46.00K -1K - - -34.00K - -
Operating Expenses 153.65M 157.95M 153.20M 93.14M 80.75M 73.19M 57.96M 32.67M 14.79M 9.32M
Interest Expense - - - 598.00K 169.00K - - - - -
Selling & Marketing Expenses - - - - - - - - - -
Cost & Expenses 153.65M 157.95M 153.20M 93.14M 80.75M 73.19M 57.96M 32.67M 14.79M 9.32M
Income Tax - -3.98M -2.92M 1.30M -691.00K -799.00K -406.00K 4.16M 64.00K 1.75M
Shares Outstanding (Basic) 56.76M 49.04M 46.32M 34.40M 25.89M 22.36M 17.69M 6.50M 5.88M 5.88M
Shares Outstanding (Diluted) 56.76M 49.04M 46.32M 34.40M 25.89M 22.36M 17.69M 6.50M 5.88M 5.88M
EPS (Basic) -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -2.52 -1.88
EPS (Diluted) -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -2.52 -1.88
EBITDA -90.34M -131.37M -123.07M -63.66M -78.31M -39.20M -36.55M -32.35M -14.55M -9.06M
Depreciation & Amortization 3.31M 1.03M 2.77M 789.00K 703.00K 527.00K 406.00K 317.00K 247.00K 258.00K